详情页 - 聚合机构库演示平台

资源类型：

文章类型：

作者：

Li, Chunrui[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] *

; Wang, Di[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16]

; Song, Yongping[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Huang, He[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16]

; Li, Jianyong[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Chen, Bing[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Liu, Jing[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16]

; Dong, Yujun[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Hu, Kai[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Liu, Peng[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16]

; Zhang, Xi[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16]

; Mi, Jian-Qing[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Li, Zhenyu[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Ding, Kaiyang[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Xu, Ai-ning[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Cai, Song-bai[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Guo, Jing-jing[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Gui, Hong-yu[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ; Wang, Wen[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16]

; Qiu, Lugui[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16] ;

单位： [1]Huazhong Univ Sci, Tongji Hosp, Dept Hematol, Tongji Med Coll, Wuhan, Peoples R China [2]Zhengzhou Univ, Affiliated Canc Hosp, Dept Hematol, Zhengzhou, Peoples R China [3]Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China [4]Zhejiang Univ, Affliated Hosp 1, Dept Hematol, Hangzhou, Peoples R China [5]Jiangsu Prov Hosp, Nanjing, Peoples R China [6]Nanjing Univ, Dept Hematol, Sch Med, Affiliated Drum Tower Hosp, Nanjing, Peoples R China [7]Cent South Univ, Xiangya Hosp 3, Dept Hematol, Changsha, Peoples R China [8]Peking Univ First Hosp, Dept Hematol, Beijing, Peoples R China [9]Beijing GoBroad Boren Hosp, Dept Adult Lymphoma, Beijing, Peoples R China [10]Fudan Univ, Zhongshan Hosp, Dept Hematol, Shanghai, Peoples R China [11]Army Med Univ, Xinqiao Hosp, Med Ctr Hematol, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China [12]Shanghai Jiao Tong Univ, State Key Lab Med Genom, Natl Res Ctr Translat Med, Shanghai Inst Hematol,Ruijin Hosp,Sch Med, Shanghai, Peoples R China [13]Xuzhou Med Univ, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China [14]USTC, Ailiated Hosp 1, Dept Hematol, Div Life Sci & Med, Hefei, Peoples R China [15]Nanjing IASO Biotherapeut Ltd, Shanghai, Peoples R China [16]Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol, Tianjin, Peoples R China

出处：

ISSN：

语种：

被引次数：

WOS：

中科院(CAS)分区：

出版当年[2022]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2021]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者单位： [1]Huazhong Univ Sci, Tongji Hosp, Dept Hematol, Tongji Med Coll, Wuhan, Peoples R China [2]Zhengzhou Univ, Affiliated Canc Hosp, Dept Hematol, Zhengzhou, Peoples R China [3]Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China [4]Zhejiang Univ, Affliated Hosp 1, Dept Hematol, Hangzhou, Peoples R China [5]Jiangsu Prov Hosp, Nanjing, Peoples R China [6]Nanjing Univ, Dept Hematol, Sch Med, Affiliated Drum Tower Hosp, Nanjing, Peoples R China [7]Cent South Univ, Xiangya Hosp 3, Dept Hematol, Changsha, Peoples R China [8]Peking Univ First Hosp, Dept Hematol, Beijing, Peoples R China [9]Beijing GoBroad Boren Hosp, Dept Adult Lymphoma, Beijing, Peoples R China [10]Fudan Univ, Zhongshan Hosp, Dept Hematol, Shanghai, Peoples R China [11]Army Med Univ, Xinqiao Hosp, Med Ctr Hematol, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China [12]Shanghai Jiao Tong Univ, State Key Lab Med Genom, Natl Res Ctr Translat Med, Shanghai Inst Hematol,Ruijin Hosp,Sch Med, Shanghai, Peoples R China [13]Xuzhou Med Univ, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China [14]USTC, Ailiated Hosp 1, Dept Hematol, Div Life Sci & Med, Hefei, Peoples R China [15]Nanjing IASO Biotherapeut Ltd, Shanghai, Peoples R China [16]Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol, Tianjin, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

CT103A, a novel fully human BCMA-targeting CAR-T cells, in patients with relapsed/refractory multiple myeloma: Updated results of phase 1b/2 study (FUMANBA-1)

文献详情